23 participants
Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-09
- Start Date:
- 2014-06-16
- Completion:
- 2021-07-07
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet